Safety and feasibility of atropine added to submaximal exercise stress testing with TI-201 SPECT for the diagnosis of myocardial ischemia

Journal of Nuclear Cardiology

Volumn 9, Issue 6, 2002, Pages 581-586

  Cosín Sales, Juan ^a   Maceira, Alicia M ^a   García Velloso, María J ^a   Macías, Alfonso ^a   Gimenez, Marta ^a   García Bolao, Ignacio ^a   Coma Canella, Isabel ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Atropine; Myocardial ischemia; Scintigraphy; Submaximal exercise testing

Indexed keywords

ATROPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOBUTAMINE; THALLIUM 201;

ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BICYCLE ERGOMETER; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG EFFECT; DRUG MECHANISM; DRUG SAFETY; EXERCISE TEST; FATIGUE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEART MUSCLE PERFUSION; HEART PALPITATION; HEART RATE VARIABILITY; HEART SCINTISCANNING; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; XEROSTOMIA;

EID: 0036868644     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1067/mnc.2002.125469     Document Type: Article

References (21)

1. Fletcher GF, Balady G, Froelicher VF, Hartley L, Haskell WL, Pollok ML. Exercise standards. A statement for healthcare professionals from the American Heart Association. Circulation 1995;91:580-615.
2. Primeau M, Taillefer R, Essiambre R, Lambert R, Honos G. Technetium 99m SESTAMIBI myocardial perfusion imaging: comparison between treadmill, dipyridamole and trans-oesophageal atrial pacing "stress" tests in normal subjects. Eur J Nucl Med 1991;18:247-51.
3. Brown KA, Rowen M. Impact of antianginal medications, peak heart rate and stress level on the prognostic value of a normal exercise myocardial perfusion imaging study. J Nucl Med 1993; 34:1467-71.
4. Gibbons RJ, Balady GJ, Beasley JW, Bricker IT, Duvernoy WFC, Froelicher VF, et al. ACC/AHA guidelines for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol 1997;30:260-315.
5. Santana Boado C, Candell Riera J, Castell Conesa J, García-Burillo A, Olona M, Paler J, et al. Diagnosis of coronary disease by means of stress gamma-tomography with 99m-technetium-isonitriles [in Spanish]. Med Clin (Barc) 1995; 105:201-4.
6. Iskandrian AS, Heo J, Kong B, Lyons E. The effect of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: analysis of 461 patients. J Am Coll Cardiol 1989;14:1477-86.
7. Verani MS, Mahmarian JJ, Hixson JB, Boyce TM, Staudacher RA. Diagnosis of coronary artery disease by controlled coronary vasodilatation with adenosine and thallium-201 scintigraphy in patients unable to exercise. Circulation 1990;82:80-7.
8. Gibbons R, Chatterjee K, Daley J, Douglas J, Fihn S, Gardin J, et al. ACC/AHA guidelines for the management of patients with chronic stable angina: executive summary and recommendations. Circulation 1999;99:2829-48.
9. 99 Tc-MIBI SPECT: improved diagnostic yield in coronary artery disease. J Am Coll Cardiol 1997;29:531-6.
10. Ellestad MH. Cardiovascular response to exercise. In: Stress testing. Principles and practice. Philadelphia: F. A. Davis; 1986.
11. Ellestad MH, Wan MK. Predictive implications of stress testing: follow-up of 2700 subjects after maximum treadmill stress testing. Circulation 1975;51:363-9.
12. Lauer MS, Okin PM, Larson MG, Evans JC, Levy D. Impaired heart rate response to graded exercise: prognostic implications of chronotropic incompetence in the Framingham Heart Study. Circulation 1996;93:1520-6.
13. Ellestad MH. Chronotropic incompetence. The implications of heart rate response to exercise (compensatory parasympathetic hyperactivity?). Circulation 1996;93:1485-7.
14. O'Leary DS, Rossi NF, Churchill PC. Substantial cardiac parasympathetic activity exists during heavy dynamic exercise in dogs. Am J Physiol 1997;273:2135-40.
15. Caner B, Karanfil A, Uysal U, Tokgozoglu L, Aksoyek S, Ugur O, et al. Effect of an additional atropine injection during dobutamine infusion for myocardial SPECT. Nucl Med Commun 1997;18:567-73.
16. McNeill AJ, Fioretti PM, el-Said SM, Salustri A, Forster A, Roelandt JR. Enhanced sensitivity for the detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol 1992;70:41-6.
17. Poldermans D, Rambaldi R, Bax A Cornel JH, Thomson IR, Valkema R, et al. Safety and utility of atropine addition during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction. Fur Heart J 1998;19:1712-8.
18. Elhendy A, van-Domburg R, Roelandt JR, Geleijnse ML, Ibrahim MM, Fioretti PM. Safety and feasibility of dobutamine-atropine stress testing in hypertensive patients. Hypertension 1997;29:1232-9.
19. Daou D, Le-Guludec D, Faraggi M, Foult JM, Lebtahi R, Cohen-Solal A, et al. Nonlimited exercise test combined with high dose dypiridamole for thallium-201 myocardial single-photon emission computed tomography in coronary artery disease. Am J Cardiol 1995;76:753-8.
20. Pennell DJ, Mavrogeni SI, Forbat SM, Karwatowski SP, Underwood SR. Adenosine combined with dynamic exercise for myocardial perfusion imaging. J Am Coll Cardiol 1995;25: 1300-9.
21. Elhendy A, van-Domburg RT, Bax JJ, Nierop PR, Geleijnse ML, Ibrahim MM, et al. The functional significance of chronotropic incompetence during dobutamine stress test. Heart 1999;81:398-403.